Valuation: GC Corp.

Market Cap 433B 291M 254M 235M 217M 409M 27.93B 416M 2.8B 1.1B 13.68B 1.09B 1.07B 47.09B P/E 2024
33.4x
P/E 2025 -10.4x
Enterprise Value 1,827B 1.23B 1.07B 992M 916M 1.73B 118B 1.76B 11.82B 4.64B 57.73B 4.61B 4.51B 199B EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
44.2%
Yield 2024
2.89%
Yield 2025 -
06-10 GC Corp.(KOSE:A005250) dropped from KOSPI 200 Index CI
05-27 Green Cross Holdings to divest 460 billion won worth of stake in Curevo RE
05-15 GC Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Green Cross Holdings Corporation acquired 22.08% stake in GREEN CROSS WellBeing Corporation from GC Biopharma Corp. for KRW 50.5 billion. CI
03-18 GC Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-10 Green Cross Holdings Corporation announces Annual dividend, payable on April 17, 2026 CI
11-14 Green Cross Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/08/25 Green Cross Holdings Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
18/06/25 Green Cross Holdings Corporation agreed to acquire an additional 23.56% stake in GC Care for KRW 71.9 billion. CI
15/05/25 Green Cross Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
18/03/25 Green Cross Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2024 CI
14/11/24 Green Cross Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
05/11/24 China Resources Boya Bio-pharmaceutical Group Co.,Ltd completed the acquisition of 100% stake in Green Cross Hk Holdings Limited from Green Cross Holdings Corporation, Synaptic 1st Private Equity Fund and others for CNY 1.82 billion. CI
1 day-2.55%
1 week-6.47%
Current month-6.93%
1 month-10.92%
3 months-31.37%
6 months-36.23%
Current year-40.08%
1 week 9,410
Extreme 9410
10,300
1 month 9,410
Extreme 9410
12,000
Current year 9,410
Extreme 9410
18,010
1 year 9,410
Extreme 9410
18,010
3 years 9,410
Extreme 9410
18,490
5 years 9,410
Extreme 9410
35,100
10 years 9,410
Extreme 9410
56,300
Manager TitleAgeSince
Chief Executive Officer 52 28/02/2010
Chief Executive Officer 72 24/03/2010
Director of Finance/CFO 53 -
Director TitleAgeSince
Chairman 72 16/12/2010
Director/Board Member 76 28/02/2009
Director/Board Member 52 28/02/2010
Date Insider Type Main position Quantity % Market Cap.
24/04/25Buy

Chief Executive Officer

3,191 0.0068%
24/04/25Buy

Chief Executive Officer

1,234 0.0026%
24/04/25Buy

Chief Executive Officer

632 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-2.55%-6.47%-43.38%-31.51% 292M
-2.48%-6.72%+44.19%+156.43% 1,028B
-1.52%-5.01%+61.87%+58.79% 611B
-1.30%-3.88%+27.81%+79.97% 432B
+0.15%-2.18%+28.47%+22.15% 323B
-0.37%-3.19%+26.88%+43.52% 277B
+0.34%-12.87%+18.22%+21.65% 257B
+0.80%-0.20%-25.54%-39.83% 217B
-1.44%-3.49%+19.60%+56.20% 192B
-1.04%-4.63%+16.01%+68.47% 161B
Average -0.63%-5.16%+17.41%+43.58% 349.86B
Weighted average by Cap. -0.35%-5.52%+33.55%+76.96%

Financials

2024 2025
Net sales 2,205B 1.48B 1.29B 1.2B 1.11B 2.08B 142B 2.12B 14.27B 5.6B 69.68B 5.56B 5.44B 240B 2,451B 1.65B 1.44B 1.33B 1.23B 2.32B 158B 2.36B 15.87B 6.23B 77.47B 6.19B 6.05B 267B
Net income 24.03B 16.14M 14.11M 13.04M 12.05M 22.69M 1.55B 23.1M 156M 61.02M 759M 60.63M 59.29M 2.61B -69.51B -46.71M -40.82M -37.73M -34.86M -65.65M -4.49B -66.83M -450M -177M -2.2B -175M -172M -7.56B
Net Debt 1,042B 700M 612M 566M 523M 984M 67.25B 1B 6.75B 2.65B 32.93B 2.63B 2.57B 113B 1,394B 937M 819M 757M 699M 1.32B 89.97B 1.34B 9.02B 3.54B 44.05B 3.52B 3.44B 152B
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
144
Date Price Change Volume
14/07/26 ₩9,540.00 -2.55% 98,614
13/07/26 ₩9,790.00 -2.59% 54,500
10/07/26 ₩10,050.00 +2.24% 62,077
09/07/26 ₩9,830.00 -1.50% 69,620
08/07/26 ₩9,980.00 -2.16% 98,885
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock